Australian Clinical Labs Limited (ASX: ACL) is a publicly traded corporate entity listed on the Australian Securities Exchange, meaning ownership is widely dispersed among institutional asset management firms, mutual funds, corporate insiders, and public retail investors. Major financial institutions and institutional equity funds hold significant aggregate stakes in the company on behalf of public market participants.